Correlation Between Vivos Therapeutics and Nu Med

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Nu Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Nu Med into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Nu Med Plus, you can compare the effects of market volatilities on Vivos Therapeutics and Nu Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Nu Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Nu Med.

Diversification Opportunities for Vivos Therapeutics and Nu Med

-0.7

Correlation Coefficient

Vivos Therapeutics  Nu Med

Excellent diversification

The 3 months correlation between Vivos and NUMD is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Nu Med Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nu Med Plus and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Nu Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nu Med Plus has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Nu Med go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Nu Med

Given the investment horizon of 90 days Vivos Therapeutics is expected to under-perform the Nu Med. But the stock apears to be less risky and, when comparing its historical volatility, Vivos Therapeutics is 2.46 times less risky than Nu Med. The stock trades about -0.02 of its potential returns per unit of risk. The Nu Med Plus is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1.80  in Nu Med Plus on October 5, 2024 and sell it today you would lose (0.26) from holding Nu Med Plus or give up 14.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.63%
Values	Daily Returns

Vivos Therapeutics  vs.  Nu Med Plus

Vivos Therapeutics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Nu Med Plus

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nu Med Plus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Vivos Therapeutics and Nu Med

The main advantage of trading using opposite Vivos Therapeutics and Nu Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Nu Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu Med will offset losses from the drop in Nu Med's long position.

The idea behind Vivos Therapeutics and Nu Med Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.